期刊文献+

Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma 被引量:12

Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma
下载PDF
导出
摘要 AIM: To determine the survival of advanced pancreatic cancer patients treated with intraoperative radiotherapy (IORT) combined with external beam radiation therapy (EBRT) following internal drainage (cholecystojejunostomy or choledochojejunostomy). METHODS: Eighty-one patients with advanced pancreatic cancer who received IORT combined with EBRT following internal drainage (ID) between 1996 and 2001 were retrospectively analyzed. Among the 81 patients, 18 underwent ID+IORT, 25 ID+IORT+EBRT (meanwhile, given 5-Fu 300 mg/m^2 iv drip, 2f/w), 16 EBRT, 22 had undergone simple internal drainage. The IORT dose was 15-25Gy in a single fraction. The usual EBRT dose was 30-40Gy with a daily fraction of 1.8-2.0 Gy. RESULTS: The complete remission rate, partial remission rate of patients with backache and abdominal pain treated with ID+IORT were 55.5%, 33.3% respectively. Alleviation of pain was observed 2 or 3 wk after IORT. The median survival time (MST) of ID+IORT group was 10.7 mo. The pain remission rate of patients treated with ID+IORT+EBRT was 92%, and their MST was 12.2 mo. The MST of patients treated with EBRT and simple internal drainage was 5.1 mo and 7.0 mo, respectively. The survival curve of ID+IORT group and ID+IORT+EBRT group was significantly better than that of EBRT group (P<0.05). The difference between the ID+IORT+EBRT group and ID group was significant (P<0.05). CONCLUSION: IORT combined with EBRT following internal drainage can alleviate pain, improve quality of life and prolong survival time of patients with advanced pancreatic cancer. AIM:To determine the survival of advanced pancreatic cancer patients treated with intraoperative radiotherapy (IORT) combined with external beam radiation therapy (EBRT) following internal drainage (cholecystojejunostomy or choledochojejunostomy). METHODS:Eighty-one patients with advanced pancreatic cancer who received IORT combined with EBRT following internal drainage (ID) between 1996 and 2001 were retrospectively analyzed.Among the 81 patients,18 underwent ID+IORT,25 ID+IORT+EBRT (meanwhile,given 5-Fu 300mg/m^2 iv drip,2f/w),16 EBRT,22 had undergone simple internal drainage.The IORT dose was 15-25Gy in a single fraction.The usual EBRT dose was 30-40Gy with a daily fraction of 1.8-2.0 Gy. RESULTS:The complete remission rate,partial remission rate of patients with backache and abdominal pain treated with ID+IORT were 55.5%,33.3% respectively.Alleviation of pain was observed 2 or 3 wk after IORT.The median survival time (MST) of ID+IORT group was 10.7 too.The pain remission rate of patients treated with ID+IORT+EBRT was 92%,and their MST was 12.2 mo.The MET of patients treated with EBRT and simple internal drainage was 5.1 mo and 7.0 mo,respectively.The survival curve of ID+IORT group and ID+IORT+EBRT group was significantly better than that of EBRT group (P<0.05).The difference between the ID+IORT+EBRT group and ID group was significant (P<0.05). CONCLUSION:IORT combined with EBRT following internal drainage can alleviate pain,improve quality of life and prolong survival time of patients with advanced pancreatic cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第11期1669-1671,共3页 世界胃肠病学杂志(英文版)
基金 Supported by the Technology Project Entry Foundation of ShaanxiProvince,No.2002K10-G3
  • 相关文献

参考文献4

二级参考文献26

  • 1Edgar Staren,Takeshi Iwamura,Hubert Appert,John Howard.Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2[J].World Journal of Gastroenterology,2001,7(1):143-148. 被引量:12
  • 2AShankar,RCGRussell.Recent advances in the surgical treatment of pancreatic cancer[J].World Journal of Gastroenterology,2001,7(5):622-626. 被引量:19
  • 3Edgar Staren,Takeshi lwamura,HubertAppert,JohnHoward.Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines[J].World Journal of Gastroenterology,2001,7(6):855-859. 被引量:7
  • 4王庆才,张磊,李苏.中医药治疗晚期胰腺癌13例[J].四川中医,1996,14(10):20-20. 被引量:20
  • 5李增灿,侯鹏,陈频佳,李杨,陈田,陈志彪,金立德,董晓秋,孟庆峰,吕蕾,孟茜莉.双介入并中药治疗胰腺癌35例[J].哈尔滨医科大学学报,1997,31(2):153-155. 被引量:5
  • 6Taylor A. Sohn M.D.,Charles J. Yeo M.D.,Jokn L. Cameron M.D.,Leonidas Koniaris M.D.,Sunjay Kaushal M.D.,Ross A. Abrams M.D.,Patricia K. Sauter A.C.N.P.,JoAnn Coleman A.C.N.P.,Ralph H. Hruban M.D.,Keith D. Lillemoe M.D.Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators[J].Journal of Gastrointestinal Surgery.2000(6)
  • 7Stephen P. Povoski M.D.,Martin S. Karpeh M.D.,Kevin C. Conlon M.D.,Leslie H. Blumgart MD.,Murray F. Brennan M.D.Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy[J].Journal of Gastrointestinal Surgery.1999(5)
  • 8W. Scott Melvin M.D.,Karl S. Buekers B.S.,Peter Muscarella M.D.,Jerome A. Johnson Ph.D.,William J. Schirmer M.D.,E. Christopher Ellison M.D.Outcome analysis of long-term survivors following pancreaticoduodenectomy[J].Journal of Gastrointestinal Surgery.1998(1)
  • 9N. L. Kelekis,R. C. Semelka.MRI of pancreatic tumors[J].European Radiology.1997(6)
  • 10John P. Neoptolemos,Pat Baker,Hans Beger,Karl Link,Paolo Pederzoli,Claudio Bassi,Christos Dervenis,Helmut Friess,Markus Büchler.Progress report: A randomized multicenter European stydy comparing adjuvant radiotherapy, 6 Mo chemotherapy, and combination therapy vs No-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)[J].International Journal of Pancreatology.1997(2)

共引文献73

同被引文献19

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部